
The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro (tirzepatide), both produced by Eli Lilly And Co. (NYSE:LLY), is false or misleading.
The agency's review found that the video misbrands the drugs by underplaying serious health risks and omitting critical safety information.